| Serial Number | 79266020 |
| Word Mark | SATIVEX |
| Filing Date | Wednesday, July 17, 2019 |
| Status | 603 - ABANDONED - AFTER EX PARTE APPEAL |
| Status Date | Monday, January 23, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 4, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GW Research Limited |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | GB |
| Party Name | GW Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Monday, August 26, 2019 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, August 22, 2019 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Wednesday, September 4, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 28, 2020 | ASSIGNED TO EXAMINER |
| Thursday, September 10, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, September 10, 2019 | APPLICATION FILING RECEIPT MAILED |
| Saturday, September 21, 2019 | ASSIGNED TO EXAMINER |
| Thursday, July 30, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, July 31, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, August 12, 2020 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Friday, August 14, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, August 15, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, September 9, 2020 | REFUSAL PROCESSED BY MPU |
| Saturday, September 26, 2020 | REFUSAL PROCESSED BY IB |
| Wednesday, January 27, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, January 27, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, February 13, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, March 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 3, 2021 | FINAL REFUSAL WRITTEN |
| Monday, May 3, 2021 | FINAL REFUSAL E-MAILED |
| Monday, May 3, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, September 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, November 8, 2021 | ASSIGNED TO LIE |
| Wednesday, November 3, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, November 3, 2021 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, November 3, 2021 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Wednesday, November 3, 2021 | EX PARTE APPEAL-INSTITUTED |
| Tuesday, November 9, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Saturday, November 20, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, January 3, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 3, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, January 3, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 5, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 5, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 6, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 17, 2022 | SUBSEQUENT FINAL REFUSAL WRITTEN |
| Wednesday, August 17, 2022 | SUBSEQUENT FINAL EMAILED |
| Wednesday, August 17, 2022 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Friday, February 10, 2023 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| Friday, December 9, 2022 | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
| Thursday, January 5, 2023 | INTERNATIONAL REGISTRATION RENEWED |
| Monday, January 23, 2023 | ABANDONMENT - AFTER EX PARTE APPEAL |
| Monday, January 23, 2023 | EXPARTE APPEAL TERMINATED |
| Friday, February 10, 2023 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| Saturday, February 10, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, February 12, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, March 11, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, May 31, 2024 | CHANGE OF OWNER RECEIVED FROM IB |